Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bronchial Basal Cell Transplantation for COPD
NCT03188627Phase 2Completed
- Sponsor
- Regend Therapeutics
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bronchial basal cells in chronic obstructive pulmonary disease (COPD), sponsored by Regend Therapeutics. Started Jun 2018; status: completed.
02
Drugs
autologous bronchial basal cells
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03188627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188627.